Journal article
Rivaroxaban in Rheumatic Heart Disease–Associated Atrial Fibrillation
Abstract
To the Editor: In the INVICTUS (Investigation of Rheumatic AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies) trial conducted by Connolly et al. (Sept. 15 issue),1 a substans...
Authors
Hammer A; Niessner A; Sulzgruber P
Journal
The New England Journal of Medicine, Vol. 387, No. 22, pp. 2100–2101
Publisher
Massachusetts Medical Society
Publication Date
December 2022
DOI
10.1056/nejmc2213437
ISSN
0028-4793